In the Media

Writing for Fortune, Prof. Elazer R. Edelman and Mike Mussallem of Edwards Lifesciences write that the backlog of deferred medical treatments caused by the Covid-19 pandemic and resulting long-term health consequences could impact public health for years. Edelman and Mussallem emphasize that “it is incumbent upon us to identify timely real-world evidence to elucidate the effects of policy changes so they can be adaptive and agile enough to provide access to critical interventions and procedures.”